Lilly to Announce Expansion of Indianapolis Insulin Manufacturing Operations

 Lilly to Announce Expansion of Indianapolis Insulin Manufacturing Operations

PR Newswire

Oct. 30

       Eli Lilly and Company (NYSE: LLY) will announce a multi-million dollar
       expansion to the company's Indianapolis insulin manufacturing
WHAT:  operations. The expanded facilities, which will manufacture high-tech
       insulin cartridges to meet the growing U.S. diabetes demand, represents
       the first increase in the company's Indianapolis manufacturing
       operations in more than two decades.
       Local and state government officials, including Indianapolis Mayor Greg
WHO:   Ballard and Lt. Governor Becky Skillman, will join officials from
       Lilly.
WHEN:  9 a.m.  Thursday, November 1
       Lilly Technology Center, 1555 S. Harding Street. From downtown, media
       should drive southwest on Kentucky Avenue to the intersection at Morris
       Street. Turn right on Morris Street. Continue on Morris Street to
WHERE: Harding Street. Take a left on Harding Street and go approximately 1
       mile to the main Lilly Technology Center entrance,which is on the left
       side of the road. Security will direct you to the ceremonies.Parking
       is available at the site.
       Important: Lilly will provide an online live stream of the press
       conference at its corporate web site, www.lilly.com A link to the live
       stream will appear on the front page of the web site.

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of pharmaceutical products by applying the latest research from its
own worldwide laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides answers-
through medicines and information- for some of the world's most urgent
medical needs. Additional information about Lilly is available at
www.lilly.com. 

Refer to: (317) 277-4021 – Greg Kueterman; kueterman_gregory_andrew@lilly.com
 (317) 433-9899 – Edward Sagebiel; egs@lilly.com

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO)

/PRNewswire -- Oct. 30/

SOURCE Eli Lilly and Company

Website: http://www.lilly.com
 
Press spacebar to pause and continue. Press esc to stop.